- Dr Dwight Nissley, Leidos Biomedical Research, Inc
- Dr Fred Streitz, Lawrence Livermore National Laboratory
- Dr Georgia Tourassi, Oak Ridge National Laboratory
- Dr Mari Nygard, Cancer Registry of Norway
- Prof Tim Hubbard, Kings College London
There is no doubt that computing and technology are central to the future for precision oncology. Rapid advances in computational approaches including large-scale machine learning, new computing technologies, exponential growth of biomedical data, and increasing volumes of available health information are the powering a new wave of advances forming the foundations for the future for precision oncology. In order to realize the promise of these transformative advances, effective translation for clinical impact is essential in areas such as preventative screening, improved disease characterization and diagnosis, discovery of new treatments, and managing post-diagnosis patient health. The symposium will bring together leaders shaping the future of precision oncology in computing, biomedical data and health information resources and management, and clinical applications to both inform and explore avenues for accelerating the translation of research advances to improved outcomes for cancer patients.
- Eric Stahlberg, Director of Biomedical Informatics and Data Science